The correlation between chronic obstructive pulmonary diseases and TB sequelae Source: Eur Respir J 2003; 22: Suppl. 45, 344s Year: 2003
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
The psychological type of chronic pulmonary TB patients Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006
Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017
Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study Source: International Congress 2019 – Airway infection in COPD Year: 2019
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011
Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001
The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
Microbiological screening infectious exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Prevalence of chronic obstructive pulmonary diseases related-hospitalization with acute exacerbation and its associated factors in Thailand. Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
Diagnosis and treatment‘s management of the MDR tuberculosis in a chronic pulmonary diseases department Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005
Detection of asthma and chronic obstructive pulmonary disease in primary care Source: Eur Respir J 2003; 21: 16S-22S Year: 2003
The prevelance of respiratory infections in vaccined patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021
The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012